Bilder in dieser Kollektion
(210131) -- BRUSSELS, Jan. 31, 2021 -- European Commission President Ursula von der Leyen (C), European Commissioner for Health and Food Safety Stella Kyriakides (L) and European Commissioner for Internal Market Thierry Breton attend a video conference in Brussels, Belgium, Jan. 31, 2021. The s (EU) top health officials held discussions on Sunday with drug giants about rapid development and production of vaccines specially against the new variants of the coronavirus. The video conference was held by the commission chief Ursula von der Leyen, with CEOs of the pharmaceutical companies BioNTech Pfizer, Moderna, AstraZeneca, Johnson & Johnson, CureVac and Sanofi, all of which have signed agreements with the EU for vaccines supply. ( Handout v
News Themen der Woche KW04 News Bilder des Tages (210131) -- BRUSSELS, Jan. 31, 2021 -- European Commission President Ursula von der Leyen attends a video conference in Brussels, Belgium, Jan. 31, 2021. The s (EU) top health officials held discussions on Sunday with drug giants about rapid development and production of vaccines specially against the new variants of the coronavirus. The video conference was held by the commission chief Ursula von der Leyen, with CEOs of the pharmaceutical companies BioNTech Pfizer, Moderna, AstraZeneca, Johnson & Johnson, CureVac and Sanofi, all of which have signed agreements with the EU for vaccines supply. ( Handout via Xinhua) BELGIUM-BRUSSELS-EU-COVID-19 VACCINE-VIDEO MEETING EuropeanxUnion
(210131) -- BRUSSELS, Jan. 31, 2021 -- European Commission President Ursula von der Leyen (C), European Commissioner for Health and Food Safety Stella Kyriakides (L) and European Commissioner for Internal Market Thierry Breton attend a video conference in Brussels, Belgium, Jan. 31, 2021. The s (EU) top health officials held discussions on Sunday with drug giants about rapid development and production of vaccines specially against the new variants of the coronavirus. The video conference was held by the commission chief Ursula von der Leyen, with CEOs of the pharmaceutical companies BioNTech Pfizer, Moderna, AstraZeneca, Johnson & Johnson, CureVac and Sanofi, all of which have signed agreements with the EU for vaccines supply. ( Handout v